Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

@inproceedings{JazayeriTehrani2017EfficacyON,
  title={Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol},
  author={Seyed Ali Jazayeri-Tehrani and Seyed Mahdi Rezayat and Siavash Mansouri and Mostafa Qorbani and Seyed Moayed Alavian and Milad Daneshi-Maskooni and Mohammad-Javad Hosseinzadeh-Attar},
  booktitle={BMJ open},
  year={2017}
}
OBJECTIVES Different studies have been conducted on the role of curcumin in health since having multiple properties, including antioxidant and anti-inflammatory effects. Due to the lack of studies regarding curcumin effects on obese patients with non-alcoholic fatty liver disease (NAFLD), our protocol was designed to assess nanocurcumin impacts on blood sugar, lipids, inflammatory indices, insulin resistance and liver function, especially by nesfatin. SETTING This trial will be conducted in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

A novel appetite peptide , nesfatin1 in patients with non - alcoholic fatty liver disease

E Akbal, S Köklü
  • Hippokratia
  • 2015

Prevalence of Non - Alcoholic Fatty liver disease in morbidly obese patients undergoing Sleeve Bariatric Surgery in Iran and Association with other Comorbid Conditions

H KarimiSari, SM MousaviNaeini, M RamezaniBinabaj
  • Jundishapur Journal of Chronic Disease Care
  • 2015

Biological and anticancer effects of curcumin

E Kamali, K Ghaedi, P Karimi
  • J Isfahan Med Sch
  • 2014